Brainsway (BWAY) Cash from Investing Activities (2018 - 2026)
Brainsway (BWAY) posted quarterly Cash from Investing Activities of -$9.3 million for Q1 2026, down 374.42% year-on-year from $3.4 million in Q1 2025, and down 802.9% on a QoQ basis from -$1.0 million in Q4 2025.
Brainsway (BWAY) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Cash from Investing Activities for 9 consecutive years, with -$9.3 million the latest figure, recorded in Q1 2026.
- Quarterly Cash from Investing Activities fell 374.42% year-over-year to -$9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.9 million (down 185.54% YoY) and the FY2025 annual result came in at -$17.5 million, down 157.62% from the prior year.
- Cash from Investing Activities slipped to -$9.3 million in Q1 2026 per BWAY's latest filing, from -$1.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for BWAY reached as high as $40.8 million in Q2 2022 and fell as low as -$35.5 million in Q4 2023.
- A 5-year average of $485294.1 and a median of -$710000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 8403.51% — and 2024, when it surged 2363.27%.
- Year by year, Cash from Investing Activities stood at $427000.0 in 2022, then tumbled by 8403.51% to -$35.5 million in 2023, then jumped by 94.8% to -$1.8 million in 2024, then soared by 43.95% to -$1.0 million in 2025, then slumped by 802.9% to -$9.3 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$9.3 million, -$1.0 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Brainsway | 598.04 Mn | 538.27 Mn | 11.68 Mn | -9.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.33 Mn |
| Mar 31, 2026 | -9.33 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | -15.86 Mn |
| Jun 30, 2025 | -15.86 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | 34.20 Mn |
| Jun 30, 2024 | 34.20 Mn |
| Mar 31, 2024 | -710,000.00 |
| Mar 31, 2024 | -710,000.00 |
| Dec 31, 2023 | -35.46 Mn |
| Dec 31, 2023 | -35.46 Mn |